Thyroidectomy is a frequent surgical treatment with a low rate of complications when carried out by well-trained surgical teams. There have been a number of advancements in minimally invasive thyroid surgery procedures during the last decade, with the main goal of improving the aesthetic outcome. These include whole endoscopic procedures with continual gas insufflation, video-assisted gasless techniques, and minimally invasive nonendoscopic thyroidectomies conducted by a minimum incision.. In the past, individuals who needed a thyroidectomy had an open procedure. MIVAT (minimally invasive video-assisted thyroidectomy) is one kind of endoscopic thyroidectomy, while others include the axillary and anterior chest approaches, as well as the axillary and bilateral axillo-breast approaches (BABA). MIVAT may be used safely in certain situations. Video aided trans axillary thyroidectomy was the primary goal of this investigation. A prospective randomised controlled trial was undertaken at the National Institute of Diabetes and Endocrinology Surgery Department and the Surgery Department at the Faculty of Medicine at Benha University. There were 30 patients in the research. All of the patients gave their permission to participate in the study. In each instance, the specifics of the surgical procedure were documented and recorded. The operational team handled all of the cases. From March 2016 to March 2020, researchers worked on this project. Results: Age in group varied from 20 to 57 years and the mean SD was 37.60 11.59 years, MBI ranged from 20 to 37 years and the mean SD was 29.17 4.62 kg/m2. There were 12 patients with hypertension (40 percent) and 9 individuals with diabetes (30 percent). Patient data show that 9 (30% of patients) had left hemithyroidectomy and 21(70% of patients) had right hemithyroidectomy, with an average operating time of 56 to 180 minutes and an SD of 83.8025.00, while blood loss was between 14 and 25 ml and an SD of 18.93 2.33, with an incision size of 4.86 0.47 cm on the average. 14 (46.7%) of the patients had multi-nodular goitre, compared to 16 (53.3%) of the patients who had solitary thyroid nodules, and the surgical margin was negative in all patients. The hospital stay varied from 1 to 2 days, and the mean SD was 1.28 0.43 days, with a standard deviation of 0.43 days. One patient (3.3 percent) experienced recurrent laryngeal nerve palsy, three patients (10 percent) had a transitory voice change, and no major organs were injured, converted, bled or required ICU care in the 26 (86.7 percent) instances where problems arose postoperatively. It is concluded that MIVAT is a safe approach when used in appropriate circumstances. If a tight adherence to the indication was followed, it should be used at mean-high-volume surgical facilities.